ATS 2019 Virtual Final Program

AMERICAN LUNG ASSOCIATION AIRWAYS CLINICAL RESEARCH CENTERS L21 TARGETING OBESE ASTHMA WITHIN THE ALA-ACRC NETWORK 12:15 p.m. - 1:15 p.m. KBHCCD Room C146 (Level 1) Target Audience Physicians, clinical scientists, nurses, paraprofessionals, educators, health care providers Objectives At the conclusion of this session, the participant will be able to: • show data on the effect of obesity on airway physiology in asthma, and discuss implications this might have for treatment; • present data on the genetics linking obesity and asthma; • discuss the effects of obesity on the risk of respiratory tract infection and to discuss ongoing treatment trials for obese asthma within the network. The obesity epidemic is having a major effect on the type of asthma commonly encountered in clinical practice. This session will highlight recent and ongoing studies within the ALA-ACRC Network that provide mechanistic insights into the relationship between obesity and asthma, and ongoing treatment trials that are being performed to target poorly controlled asthma in this patient population. Chairing: W.C. Bailey, MD, Birmingham, AL 12:15 Effects of Obesity on Airway Physiology in Asthma U. Peters, MSc, PhD, Burlington, VT 12:25 The Opening Index as a Marker of Airway Closure in Children with Asthma E.L. McGuire, MD, Durham, NC 12:35 Risk of Respiratory Tract Infections in Obese Patients with Asthma M. Tang, MD, Durham, NC 12:45 Genetics of Obesity and Asthma J. Lang, MPH, MD, Durham, NC 12:55 ALA-ACRC Trials in Progress for Obese Patients with Poorly Controlled Asthma A.E. Dixon, MD, ATSF, Burlington, VT 1:05 Discussion/Questions and Answers R.A. Wise, MD, Baltimore, MD NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIH L22 ASTHMA PHENOTYPES’ RISK FACTORS AND ROLE OF RESPIRATORY VIRUSES AND BACTERIA IN EXACERBATIONS: LESSONS FROM THE NIAID, NIH INNERCITY ASTHMA CONSORTIUM 12:15 p.m. - 1:15 p.m. KBHCCD Room C155-C156 (Level 1) Target Audience Clinicians, researchers, health care administrators, public health specialists, asthma educators Objectives At the conclusion of this session, the participant will be able to: • learn new findings on how phenotypes evolve between 7 and 10 years of age and the implication for asthma; • learn the risk factors associated with phenotypes; • understand the pathways through which respiratory viruses and bacteria influence asthma exacerbations. Data through 10 years of age from the Inner City Asthma Consortium (ICAC) URECA birth cohort will provide insight into the distinct risk factors for asthma phenotypes and the impact these phenotypes on asthma development and persistence. A one year follow-up of 6 to 17 year old asthmatics provides the data necessary to evaluate the pathways through which respiratory viruses and bacteria influence asthma exacerbations. Chairing: P.J. Gergen, MD, MPH, Rockville, MD 12:15 Distinct Risk Factors for Asthma Phenotypes in Urban Children J.E. Gern, MD, Madison, WI 12:45 What Are the Pathways to Asthma Exacerbations with Respiratory Viruses and Bacteria? M.C. Altman, MD, Seattle, WA VARIOUS ORGANIZATIONS L23 RESEARCH FUNDING OPPORTUNITIES 12:15 p.m. - 1:15 p.m. KBHCCD Room D162/D164 (Level 1) Target Audience Any ATS members who are conducting research and seeking research funding Objectives At the conclusion of this session, the participant will be able to: • describe the research priorities of each funding agency represented on the panel; • identify specific criteria and mechanisms of funding from each agency on the panel; • identify a funding agency that is most closely aligned with the attendee’s research interest/program of research. This session will introduce programs and research grant opportunities offered from various funding agencies. Speakers will present current research priorities and mechanisms of research funding available from each agency. Opportunity will be provided for audience questions of the panel of speakers. Chairing: J.L. Guttormson, PhD, Milwaukee, WI A.M. Russell, MScN, London, United Kingdom 12:15 ATS Foundation E.M. Nebel, MA, New York, NY ATS 2019 • Dallas, TX WEDNESDAY • MAY 22 369 WEDNESDAY MID-DAY